Economic burden of multimorbidity in patients with severe asthma: a 20-year population-based study

Abstract

Comorbidities accounted for more than half of the incremental medical costs in patients with severe asthma. This highlights the importance of considering the burden of multimorbidity in evidence-informed decision making for patients with severe asthma.